OC-0251: Electromagnetic tracking for error detection in interstitial brachytherapy  by Kellermeier, M. et al.
ESTRO 35 2016                                                                                                                                                    S115 
______________________________________________________________________________________________________ 
 
Proffered Papers: Brachytherapy 3: Detectors and dose 
verification  
 
 
OC-0251  
Electromagnetic tracking for error detection in interstitial 
brachytherapy 
M. Kellermeier1, D. Elz1,2, V. Strnad1,2, C. Bert
1University Clinic Erlangen, Radiation Oncology, Erlangen, 
Germany 
1,2 
2Friedrich-Alexander Universität Erlangen-Nürnberg, 
Radiation Oncology, Erlangen, Germany 
 
Purpose or Objective: Catheter reconstruction errors, wrong 
indexer length and misidentified first dwell position are 
among the most common medical events related to high-
dose-rate brachytherapy (HDR-BT) treatment, reported in the 
United States by the Nuclear Regulatory Commission. The 
purpose of this study is a feasibility analysis for the detection 
of such events based on electromagnetic tracking (EMT). 
 
Material and Methods: In a phantom-based experiment 
series, swap of catheters and displacement (Δl = 0, 1, 2, 3, 4, 
5 and 6 mm) of a single catheter along direction of insertion 
were simulated. For the detection of errors the measured 
implant geometry was registered to the nominal one. Then 
the residual distances between corresponding dwell positions 
were analyzed. 
Within an IRB approved study the breast implants of 18 
patients treated with HDR interstitial brachytherapy (HDR-
iBT) were measured by EMT after implantation, after CT 
imaging in imaging position, and as part of each of 9 
treatment fractions in treatment position. The data were 
used to simulate catheter reconstruction errors, wrong 
indexer length, and swapping of catheters. Based on 
determining the pairwise difference of all EMT-reconstructed 
dwell positions and by registering the measured implant 
geometry with the nominal one established during treatment 
planning, the feasibility of error detection by EMT was 
tested. 
 
Results: Swapping of catheters can be detected in phantoms. 
The shift of individual catheters was detected quantitatively 
within the determined EMT-accuracy (95th percentile of 0.83 
mm). For example, the shift of Δl = 6 mm resulted in an EMT-
determined shift of 6.09 mm compared to measured values of 
< 0.8 mm for all catheters without an induced shift. 
First analyses of the data indicate that pairwise differences 
result into a catheter specific “fingerprint” (see figure 1a for 
catheters 5-8). This fingerprint stays stable over multiple 
fractions (figure 1b for DICOM treatment planning, fractions 
2, 4) such that, e.g., a swap as simulated in fraction 4 (fig. 
1b) can easily be identified.  
 
 
 
Conclusion: EMT is a promising technique for error detection 
in interstitial brachytherapy. Further analysis of our clinical 
data will be conducted to determine the sensitivity and 
specificity of the proposed error detection methods.  
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Purpose or Objective: In low dose rate (LDR) brachytherapy, 
seed misplacement/movement is common and may result in 
deviation from the planned dose. Current imaging standards 
for seed position verification are limited in either spatial 
resolution or ability to provide seed positioning information 
during treatment. BrachyView (BV) is a novel, in-body 
imaging system which aims to provide real-time high 
resolution imaging of LDR seeds within the prostate. 
 
Material and Methods: The BV probe consists of a gamma 
camera with three single cone pinhole collimators in a 1 mm 
thick tungsten tube. Three, high resolution, pixelated 
detectors (Timepix) are placed directly below. Each detector 
comprises of 256 x 256 pixels, each 55 × 55 µm2 in area. The 
system is designed to reconstruct seed positions by finding 
the centre of mass of the seed projections on the detector 
plane. Back projection image reconstruction is adopted for 
seed localisation.  
A thirty seed LDR treatment plan was devised. I-125 seeds 
were implanted within a CIRS tissue-equivalent ultrasound 
prostate gel phantom. The prostate volume was imaged with 
transrectal ultrasound (TRUS). The BV probe was placed in-
phantom to image the seeds. A CT scan of the setup was 
performed. CT data were used as the true location of seed 
positions, as well as reference when performing the image 
co-registration between the BV coordinate system and TRUS 
coordinate system.  
An in-house graphical user interface was developed to 
perform 3D visualisation of the prostate volume with the 
seeds in-situ. The BV and CT-derived source locations were 
compared within the prostate volume coordinate system for 
evaluation of the accuracy of the reconstruction method. A 
Dose Volume Histogram (DVH) study of the Clinical Target 
Volume (CTV) was performed using TG-43 calculations, using 
reconstructed source positions provided by BV system and CT 
scanner. 
 
Results: Figure 1 (a) shows the reconstructed prostate 
volume using ultrasound slices. The reconstructed seed 
positions using BV probe and CT images are merged with the 
prostate volume (shown in same coordinate system). (b) 
shows the discrepancy between calculated seed positions 
using CT and BV datasets. (c) shows the DVH calculated from 
CT data set and BV probe. 
 
